NeuroOne Medical Technologies Corporation (NMTC)

Market Cap	23.38M
Revenue (ttm)	3.45M
Net Income (ttm)	-12.32M
Shares Out	30.84M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,485
Open	0.758
Previous Close	0.758
Day's Range	0.730 - 0.770
52-Week Range	0.551 - 1.720
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 17, 2024

About NMTC

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to dev...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 16
• Stock Exchange: NASDAQ
• Ticker Symbol: NMTC
• Website: https://www.n1mtc.com

Financial Performance

In 2024, NMTC's revenue was $3.45 million, an increase of 1.33% compared to the previous year's $3.41 million. Losses were -$12.32 million, 3.87% more than in 2023.